Æó¾ÏÀÇ ¹æ»ç¼±Ä¡·á °á°ú
Result of Radiation Therapy for the Lung Cancer

´ëÇÑÄ¡·á¹æ»ç¼±°úÇÐȸÁö 1989³â 7±Ç 2È£ p.213 ~ p.225

±èÁÖ¿µ(Kim Joo-Young) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Ä¡·á¹æ»ç¼±°ú
ÃÖ¸í¼±(Choi Myung-Sun) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Ä¡·á¹æ»ç¼±°ú
¼­¿øÇõ(Suh Won-Hyuck) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Ä¡·á¹æ»ç¼±°ú

Abstract

An analysis has been made of two hundred seven patients who were treated at the department of Radiation Oncology of Korea University Hospital for lung cancer from January 1981 through December 1986. There were 137 patients of nonsmall cell carcinoma (137/207, 66%), 26 patients of small cell carcinoma (26/207, 12.5%) and 44 patients of unproven histology, By aims of treatment, there were 104 patients (104/207, 50%) treated for cure, 89 patients (89/207, 42.9%) for palliation and 14 patients teated postoperatively. In 22 out of 207 patients, chemotherapy was done with radiotherapy, 12 of which were patients with small cell carcinoma. Stage II patients were 49(49/207, 23.6%), stage III patients were 157(157/207, 75.8%) and one patient had an occult cancer. The tumor was initially measured by CAT scan and chest X-rays in the 165 (165/207, 79.7%)patients, among which 117 patients had tumor diameter more than 5cm and 48 patients less than 5cm. Radiation therapy was given with Cobalt 60 teletherapy unit and the treatment volume encompassed primary tumor and the mediastinum. For curative aim, daily tumor dose of 180 cGy was given up to the range of 5,400~6,120 cGy/30~34 F/6~7 week period and for palliative aim, daily tumor dose of 300 cGy was given up to the range of 3,600 ~ 4,500 cGy/12~15 F/2~3 week period.

Å°¿öµå

Lung Cancer, Radiotherapy
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
For curative aim, daily tumor dose of 180 cGy was given up to the range of 5,400~6,120 cGy/30~34 F/6~7 week period and for palliative aim, daily tumor dose of 300 cGy was given up to the range of 3,600 ~ 4,500 cGy/12~15 F/2~3 week period.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå